| Dr Jane Ellery Broecker, MD | |
|
75 Hospital Dr, Suite 260, Athens, OH 45701-2857 | |
| (740) 594-8819 | |
| (740) 594-4090 |
| Full Name | Dr Jane Ellery Broecker |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 26 Years |
| Location | 75 Hospital Dr, Athens, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548360852 | NPI | - | NPPES |
| 2301833 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35.076838 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohiohealth O'bleness Hospital | Athens, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ohiohealth Corporation | 6305758426 | 1900 |
News Archive
Akorn, Inc., a niche specialty pharmaceutical company, today announced that it has launched Vancomycin Hydrochloride USP 125mg and 250mg capsules, the generic version of ViroPharma's Vancocin, which is indicated for the treatment of Clostridium difficile-associated diarrhea.
EpiCept Corporation today announced operating and financial results for the three and nine months ended September 30, 2010, and provided an update with respect to the Company's key business initiatives.
Neurologix, Inc. announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.
CANCER Research UK scientists have discovered how some cancer cells choose to live and others die following anti-cancer treatment, unveiling their findings in the prestigious journal PNAS today.
Tengion, Inc. a leader in regenerative medicine, presented new data on Saturday, October 23, 2010 in a podium presentation at the American Society for Transplantation's Annual Scientific Exchange in Orlando, FL. The presentation highlighted new early data from Tengion's Neo-Kidney Augment development program demonstrating promising improvements in kidney function with an autologous cellular therapy approach to kidney regeneration in a canine model of chronic kidney disease.
› Verified 6 days ago
| Entity Name | Ohiohealth Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545273 PECOS PAC ID: 6305758426 Enrollment ID: O20031105000532 |
News Archive
Akorn, Inc., a niche specialty pharmaceutical company, today announced that it has launched Vancomycin Hydrochloride USP 125mg and 250mg capsules, the generic version of ViroPharma's Vancocin, which is indicated for the treatment of Clostridium difficile-associated diarrhea.
EpiCept Corporation today announced operating and financial results for the three and nine months ended September 30, 2010, and provided an update with respect to the Company's key business initiatives.
Neurologix, Inc. announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.
CANCER Research UK scientists have discovered how some cancer cells choose to live and others die following anti-cancer treatment, unveiling their findings in the prestigious journal PNAS today.
Tengion, Inc. a leader in regenerative medicine, presented new data on Saturday, October 23, 2010 in a podium presentation at the American Society for Transplantation's Annual Scientific Exchange in Orlando, FL. The presentation highlighted new early data from Tengion's Neo-Kidney Augment development program demonstrating promising improvements in kidney function with an autologous cellular therapy approach to kidney regeneration in a canine model of chronic kidney disease.
› Verified 6 days ago
| Entity Name | Athens Medical Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982714358 PECOS PAC ID: 9537112685 Enrollment ID: O20050301000331 |
News Archive
Akorn, Inc., a niche specialty pharmaceutical company, today announced that it has launched Vancomycin Hydrochloride USP 125mg and 250mg capsules, the generic version of ViroPharma's Vancocin, which is indicated for the treatment of Clostridium difficile-associated diarrhea.
EpiCept Corporation today announced operating and financial results for the three and nine months ended September 30, 2010, and provided an update with respect to the Company's key business initiatives.
Neurologix, Inc. announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.
CANCER Research UK scientists have discovered how some cancer cells choose to live and others die following anti-cancer treatment, unveiling their findings in the prestigious journal PNAS today.
Tengion, Inc. a leader in regenerative medicine, presented new data on Saturday, October 23, 2010 in a podium presentation at the American Society for Transplantation's Annual Scientific Exchange in Orlando, FL. The presentation highlighted new early data from Tengion's Neo-Kidney Augment development program demonstrating promising improvements in kidney function with an autologous cellular therapy approach to kidney regeneration in a canine model of chronic kidney disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jane Ellery Broecker, MD 5450 Frantz Rd Ste 360, Dublin, OH 43016-4141 Ph: (614) 544-6155 | Dr Jane Ellery Broecker, MD 75 Hospital Dr, Suite 260, Athens, OH 45701-2857 Ph: (740) 594-8819 |
News Archive
Akorn, Inc., a niche specialty pharmaceutical company, today announced that it has launched Vancomycin Hydrochloride USP 125mg and 250mg capsules, the generic version of ViroPharma's Vancocin, which is indicated for the treatment of Clostridium difficile-associated diarrhea.
EpiCept Corporation today announced operating and financial results for the three and nine months ended September 30, 2010, and provided an update with respect to the Company's key business initiatives.
Neurologix, Inc. announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.
CANCER Research UK scientists have discovered how some cancer cells choose to live and others die following anti-cancer treatment, unveiling their findings in the prestigious journal PNAS today.
Tengion, Inc. a leader in regenerative medicine, presented new data on Saturday, October 23, 2010 in a podium presentation at the American Society for Transplantation's Annual Scientific Exchange in Orlando, FL. The presentation highlighted new early data from Tengion's Neo-Kidney Augment development program demonstrating promising improvements in kidney function with an autologous cellular therapy approach to kidney regeneration in a canine model of chronic kidney disease.
› Verified 6 days ago
Tzvetan Fatchikov, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 75 Hospital Dr Ste 260, Athens, OH 45701 Phone: 740-594-8819 Fax: 740-594-4099 | |
J. Jack Chan, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 86 Columbus Rd, Ste 203, Athens, OH 45701 Phone: 740-594-2624 Fax: 740-594-7333 | |
Maggie Rechel, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 75 Hospital Dr Ste 260, Athens, OH 45701 Phone: 740-594-8819 Fax: 740-594-4099 | |
Dr. Jody M Gerome, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 75 Hospital Dr, Suite 260, Athens, OH 45701 Phone: 740-594-8819 | |
Dr. Michael J Clark, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4411 Fisher Rd, Athens, OH 45701 Phone: 740-591-8118 | |
Dr. Timothy Tulley Kermode, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 75 Hospital Dr, Suite 260, Athens, OH 45701 Phone: 740-594-8819 Fax: 740-594-4099 | |
Dr. Jack M Ramey, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 26 E Park Dr Ste 105b, Athens, OH 45701 Phone: 740-331-6912 Fax: 740-331-6913 |